electroCore, Inc. (ECOR)
NASDAQ: ECOR · IEX Real-Time Price · USD
6.00
-0.20 (-3.23%)
At close: Jul 19, 2024, 4:00 PM
5.93
-0.07 (-1.17%)
Pre-market: Jul 20, 2024, 9:29 AM EDT
electroCore Revenue
electroCore had revenue of $18.69M in the twelve months ending March 31, 2024, with 97.33% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $5.44M with 95.79% year-over-year growth. In the year 2023, electroCore had annual revenue of $16.03M with 86.57% growth.
Revenue (ttm)
$18.69M
Revenue Growth
+97.33%
P/S Ratio
2.07
Revenue / Employee
$274,897
Employees
68
Market Cap
38.68M USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 16.03M | 7.44M | 86.57% |
Dec 31, 2022 | 8.59M | 3.14M | 57.62% |
Dec 31, 2021 | 5.45M | 1.96M | 55.93% |
Dec 31, 2020 | 3.50M | 1.11M | 46.25% |
Dec 31, 2019 | 2.39M | 1.40M | 140.72% |
Dec 31, 2018 | 992.95K | 181.50K | 22.37% |
Dec 31, 2017 | 811.46K | 557.32K | 219.30% |
Dec 31, 2016 | 254.14K | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
The Oncology Institute | 342.71M |
Nortech Systems | 138.66M |
Concord Medical Services Holdings | 75.80M |
Curis | 9.81M |
Mobile-health Network Solutions | 7.87M |
ECOR News
- 26 days ago - electroCore Announces the Commercial Launch of TAC-STIM™ - GlobeNewsWire
- 6 weeks ago - electroCore, Inc. Announces $9.3 Million Registered Direct Offering and Concurrent Private Placements Priced At Market Under Nasdaq Rules - GlobeNewsWire
- 2 months ago - electroCore Announces First Quarter 2024 Financial Results - GlobeNewsWire
- 2 months ago - electroCore Announces Inducement Grant under NASDAQ Listing Rule 5635(c)(4) - GlobeNewsWire
- 2 months ago - electroCore to Announce First Quarter March 31, 2024 Financial Results on Wednesday, May 8, 2024 - GlobeNewsWire
- 2 months ago - Truvaga™ Plus Demonstrates Health Benefits in Latest Consumer Study, Paving the Way for Market Expansion - GlobeNewsWire
- 3 months ago - electroCore Announces the Launch of Truvaga Plus® for General Wellness - GlobeNewsWire
- 3 months ago - electroCore Expands Intellectual Property Portfolio - GlobeNewsWire